Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Insufficiency,Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00226902
What this trial is testing

Vascular Reactivity in Kidney Disease Patients

Who this might be right for
Kidney Failure, ChronicDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Melbourne Health 15
Not applicableStudy completedNCT05552339
What this trial is testing

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Bayer 348
Post-approval studies (Phase 4)Study completedNCT01617824
What this trial is testing

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesChronic Renal Failure
University of Padova 45
Large-scale testing (Phase 3)Study completedNCT01316094
What this trial is testing

Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 165
Testing effectiveness (Phase 2)Study completedNCT04515849
What this trial is testing

Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Diseases
AstraZeneca 248
Early research (Phase 1)Study completedNCT01407276
What this trial is testing

Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

Who this might be right for
Chronic Renal InsufficiencyType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 49
Not applicableStudy completedNCT04136951
What this trial is testing

Improving Patient Prioritization During Hospital-homecare Transition

Who this might be right for
Diabetes Mellitus, Type 2Congestive Heart FailureObstructive Pulmonary Disease+2 more
Columbia University 1,915
Not applicableUnknownNCT04058951
What this trial is testing

Plant Versus Animal Dietary Protein and the Effect on Proteinuria

Who this might be right for
Kidney InsufficiencyDiabetes MellitusDiabetes Mellitus, Type 2+6 more
Jens Rikardt Andersen 20
Very early researchEnrolling By InvitationNCT07209527
What this trial is testing

Truway Diagnostic Tools in Primary Care

Who this might be right for
Chronic DiseaseType 2 Diabetes Mellitus (T2DM), Obesity, OverweightHypertension+6 more
Truway Health, Inc. 200
Early research (Phase 1)Study completedNCT02014259
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 71
Early research (Phase 1)Study completedNCT00418366
What this trial is testing

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Who this might be right for
Renal InsufficiencyHemodialysis
Merck Sharp & Dohme LLC 24
Early research (Phase 1)WithdrawnNCT01551446
What this trial is testing

Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen
Testing effectiveness (Phase 2)Study completedNCT00421733
What this trial is testing

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
Abbott 281
Large-scale testing (Phase 3)Study completedNCT01164501
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Boehringer Ingelheim 741
Not applicableLooking for participantsNCT04802395
What this trial is testing

Real World Evidence Clinical Utility Study of KidneyIntelX

Who this might be right for
Chronic Kidney DiseasesDiabetic Kidney Disease
Renalytix AI, Inc. 10,000
Not applicableActive Not RecruitingNCT05198284
What this trial is testing

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney DiseasesChronic Kidney Disease Stage 1+2 more
Renalytix AI, Inc. 2,000
Not applicableStudy completedNCT03826381
What this trial is testing

NAFLD Among Patients With Type 2 Diabetes and CKD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Kidney DiseasesType2 Diabetes
Rigshospitalet, Denmark 100
Testing effectiveness (Phase 2)Study completedNCT00770640
What this trial is testing

Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.

Who this might be right for
Diabetes Mellitus
Takeda 40
Early research (Phase 1)Looking for participantsNCT07807059
What this trial is testing

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

Who this might be right for
Overweight/ObesityMetabolic Dysfunction-associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH)Type 2 Diabetes Mellitus
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT01399580
What this trial is testing

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 48
Next Page